Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, USA.
Curr Pharm Biotechnol. 2011 Jan 1;12(1):42-53. doi: 10.2174/138920111793937880.
Unique among ion channels, TRPM6 and TRPM7 garnered much interest upon their discovery as the first ion channels to possess their own kinase domain. Soon after their identification, the two proteins were quickly linked to the regulation of magnesium homeostasis. However, study of their physiological functions in mouse and zebrafish have revealed expanding roles for these channel-kinases that include skeletogenesis and melanopore formation, thymopoiesis, cell adhesion, and neural fold closure during early development. In addition, mutations in the TRPM6 gene constitute the underlying genetic defect in hypomagnesemia with secondary hypocalcemia, a rare autosomal-recessive disease characterized by low serum magnesium accompanied by hypocalcemia. Depletion of TRPM7 expression in brain, on the other hand, proved successful in mitigating much of the cellular devastation that accompanies oxygen-glucose deprivation during ischemia. The aim of this review is to summarize the data emerging from molecular genetic, biochemical, electrophysiological, and pharmacological studies of these unique channel-kinases.
在离子通道中,TRPM6 和 TRPM7 是独一无二的,因为它们是第一个拥有自己激酶结构域的离子通道。在发现它们之后不久,这两种蛋白质就被迅速与镁稳态的调节联系起来。然而,对其在小鼠和斑马鱼中的生理功能的研究揭示了这些通道激酶的扩展作用,包括骨骼发生和黑素体形成、胸腺生成、细胞黏附和早期发育过程中的神经褶闭合。此外,TRPM6 基因的突变构成了低镁血症伴低钙血症的潜在遗传缺陷,这是一种罕见的常染色体隐性疾病,其特征是血清镁含量低,伴有低钙血症。另一方面,在大脑中耗尽 TRPM7 的表达,成功地减轻了在缺血期间伴随缺氧葡萄糖剥夺而来的大部分细胞破坏。本综述的目的是总结这些独特的通道激酶的分子遗传、生化、电生理和药理学研究中出现的数据。